e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A new assay for the diagnosis of tuberculosis infection in an unselected population
I. Gerogianni, M. Papala, D. Klapsa, E. Zinzaras, E. Petinaki, K. Gourgoulianis (Larissa, Greece)
Source:
Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Session:
Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Session type:
Electronic Poster Discussion
Number:
255
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Gerogianni, M. Papala, D. Klapsa, E. Zinzaras, E. Petinaki, K. Gourgoulianis (Larissa, Greece). A new assay for the diagnosis of tuberculosis infection in an unselected population. Eur Respir J 2007; 30: Suppl. 51, 255
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
The detection of tuberculosis in immunocompromised host as a high-risk group during TB control in Ukraine
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine.
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018
The set of immunological tests for detection of active tuberculosis in children with latent infection
Source: International Congress 2019 – Paediatric tuberculosis
Year: 2019
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
The definition of tuberculosis infection based on the spectrum of tuberculosis disease
Source: Breathe, 17 (3) 210079; 10.1183/20734735.0079-2021
Year: 2021
Performance of the tuberculin skin test and Interferon-gamma release assays for detection of tuberculosis infection in immunocompromised patients in a TB endemic population
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
The diagnosis and treatment results of new diagnosed tuberculosis cases
Source: Eur Respir J 2002; 20: Suppl. 38, 166s
Year: 2002
Our experience of T cell assays in the diagnosis of MTB disease and latent infection
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016
A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005
Multiple cytokine response to
mycobacterium tuberculosis
with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Performance of IFN-γ release assays for tuberculosis detection in immune-compromised children in a low prevalence country
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006
Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection
Source: International Congress 2017 – Migrants and screening
Year: 2017
New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
The value of interferon-γ assay for the diagnosis of TB meningitis in children
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept